gist of it is that the system we live (and some die) under is only
equipped to save lives when there is profit to be made. Here is a
summary, but it’s worth reading it all.
companies are not interested in developing drugs for use with acute
respiratory infections such as Covid-19. Their investment is in drugs
for chronic diseases, such as aids and Hepatitis B.
years ago, many Big Pharma companies had antiviral-drug programmes.
Now there are few.
was working on broad-spectrum antivirals for respiratory infections
like Covid-19, but in 2015 the project was shut down.
The capitalist economy within which the pharmaceutcals flourish demand a return on their investment.
they tried to develop an antiviral for Covid-19; by the time it would
be available novel Coronavirus would have gone. Where’s the profit in
will always be people dying of cancer, but pandemics arrive
infrequently and don’t necessarily stay for long—characteristics
that make drug research and development a commercial liability.
pandemics move fluidly across borders there must be global
clinical data gathered from multiple countries.
World Health Organization has attempted this with its International
Solidarity Trial, but it's too limited. With Donald Trump
withdrawing US support from WHO it is also too risky.
the absence of international funding, research and development,
public health depends on those who have both wealth and intelligence.
For example the Bill and Melinda Gates Foundation, Wellcome, and
Mastercard pledged a hundred and twenty-five million dollars for Covid-19 research to help overcome some of the market
impediments to drug development.
is the third coronavirus outbreak in two decades. There is,
undoubtedly, a fourth on the horizon.
is no way to predict what disease it will cause—it won’t be SARS
or MERS or Covid-19, but certain things will be the same. Masks will be necessary, the streets will empty, fear will take hold and people will die
only health Big Pharma will be looking out for is a healthy return on their